In a recent study published in the Molecular Therapy journal, researchers assessed the efficacy of the scFv76 antibody against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lung damage.
In a recent study posted to the medRxiv* preprint server, researchers assessed the superposition of aerosol and droplets in coronavirus disease 2019 (COVID-19) transmission. Study: Superposition of ...